SCHLAP1 and prostate carcinoma: For example, we found the pca-lncRNAs SCHLAP1 and PCAT14, both known to be enriched in prostate cancer cells, to exhibit upregulation (logFC = 1.28, FDR = 1.63 × 10−2) and downregulation (logFC = −3.77, FDR = 1.83 × 10−20), respectively, in metastases compared to primary tumors.